NanoVibronix Inc. (NASDAQ: NAOV) stock gained by 17.65% at the last close whereas the NAOV stock price declines by 5.51% in the after-hours trading session. NanoVibronix is a medical device business based in Elmsford, New York, with research and innovation in Nesher, Israel. Its proprietary low-intensity surface acoustic wave (SAW) technology is utilized to produce medical devices.
NAOV sock’ Recent Development
NAOV announced that its randomized, double-blind trial which was performed at Birmingham Orthopedic and Sports Specialists in Birmingham, Alabama, yielded excellent outcomes.
Clinicians from Birmingham Orthopedic and Sports Specialists have completed a randomized, double-blind trial to assess the NanoVibronix PainShield’s safety and efficacy. An orthopedic surgeon examined the patients in the research for lateral epicondylitis, often known as tennis elbow, which is a swelling or tearing of the tendons in the arm. Discomfort or aching on the outside of the arm, where the forearm joins the elbow, is a symptom. At the start of the trial, all of the patients in the study experienced pain and joint soreness, and they had been following standard treatment guidelines, which had failed to give pain relief. In contrast, 91 percent of patients in the PainShield therapy group achieved total or partial symptom relief at the end of the trial. Patients used PainShield alongside over-the-counter medications as required, but without the advantage of opioid-based prescription medicine.
Brian Murphy, CEO of NAOV stock, commented,
The findings of the Birmingham research confirm that PainShield is a safe, simple-to-use, and incredibly efficient treatment for soft tissue pain. Patients in the research who used their device experienced significant pain relief, and when coupled with over-the-counter anti-inflammatory medicines, they reported total symptom remission within 10 days.
Dr. David Lemak, the Lead Investigator of the Birmingham Study, stated,
The use of PainShield drastically enhanced patient outcomes, and no patients reappeared with signs or symptoms of an exacerbation. The outcomes they were able to accomplish for the patients without the use of prescribed opioid medicines, which may sometimes lead to long-term usage and addiction, are very promising.
Leave a Reply